Navigation Links
inVentiv Health Reports Record Financial Results for Fourth Quarter and Full Year 2007
Date:2/28/2008

iluted earnings per share from

continuing operations, as adjusted $1.80 - $1.90

Twelve- Months

Proforma Growth Rate on a Net Revenue Basis Ended December 31,

(unaudited) 2007 vs 2006

Growth rate, as reported 26%

Less: Acquisition Growth Rate (13%)

Growth rate, proforma 13%


'/>"/>
SOURCE inVentiv Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. inVentiv Health Ranked #17 by Training Magazine in its 2008 List of Top 125 Training Companies
2. inVentiv Health to Announce Fourth Quarter and Full Year 2007 Results and Conduct Conference Call on Thursday, February 28th
3. inVentiv Health Provides Updated Information on December 11th Investor Day
4. inVentiv Health Creates Client Development and Integration Team
5. inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference
6. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
7. inVentiv Health to Announce Third Quarter Results and Conduct Conference Call on Wednesday, November 7, 2007
8. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
9. Crdentia Selected by Leading Staffing Vendor to Provide Health Care Staffing Services to One of the Largest Hospital Chains in the U.S.
10. Former Blue Cross/Blue Shield Account Manager Sentenced for Health Care Fraud Scheme, Tax Evasion
11. UCLA launches network to study health care disparities affecting minorities

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...k in the Journal of Neurosurgery: Pediatrics fin...cytic Astrocytoma, or JPA, tumors in the thalamus ...r Imaging, or DTI. The sensitivity of DTI imaging...es in the brain. This information can maximize th... avoiding damage to the fiber bundles that are dir...
(Date:12/4/2009)... Corp., a leading manufacturer of over-the-counter...enhance consumers’ quality of life, today an...can Podiatric Medical Association (APMA) Seal of A...iFeet®. , (PRWEB) De...urer of over-the-counter topical cream and first a...
(Date:12/4/2009)..., Dec. 4 , ,What: Humana...care, health benefits provider, is i...agames.com ), a senior-friendly dance pad, ... on Tues., Dec. 8 at 1 p.m. The fes...d open to the public, will feature Dancetown, ...
(Date:12/4/2009)...4 PLUS Diagnostics announced tod...hology services with the launch of a national hema...s the company,s expansion from a regional laborato...y offering diagnostic services across a full range...y and now hematology/oncology. ,, PLUS Diagnos...
(Date:12/4/2009)...PRNewswire/ -- The National Cancer Institute has a...Fred Hutchinson Cancer Research Center to become t...n Service Contact Center. ,, The move will crea...ripling the size of its current CIS workforce - on...hich is scheduled for March 15, 2010. The Seattle ...
Breaking Medicine News(10 mins):Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 2Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 3Health News:Tender Corp.'s HealthiFeet Awarded American Podiatric Medical Association Seal of Approval 4Health News:Humana Launches Dancetown on Tues., Dec. 8 in Kissimmee 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 2Health News:PLUS Diagnostics Launches Hematology/Oncology Diagnostic Services 3Health News:Hutchinson Center Wins $55.4 Million Contract to Become Sole Operator of the NCI Cancer Information Service 2
... Smokers who have an easier ...es that can foster success, according to a new stu... Institute on Drug Abuse. , ... according to a new study by a team of federal sci...
...linical pharmacy services can significantly reduce...ewhere in the health care system, according to a n...ois at Chicago. , For every dollar spent by hospi...on errors and other savings, says Glen Schumock, a...
...ing may help unravel how diseases form, , ...ne acting very differently in different tissues ma...w likely a person is to get a disease, a new repor...Such variation can lead to alternative splicing, a...
...y points to 16 states where Medicaid doesn,t fund ... News) -- Thousands of male infants aren,t being c...over the procedure through Medicaid, new research ... policy at the University of California, Los Angel...
...he use of radiation therapy to treat cancer inevit... the benefits of this treatment have been well est...ing complications as a result injury to normal tis.... , A research article to be published on Decemb...
...ing a favorite ritual might ease a friend or famil...lthDay News) -- If a family member or friend is in...r them up by bringing a bit of Christmas from home...ist Hospital in Houston, said in a hospital news r...
Other Medicine News:Health News:Studies on Smoking Genes and Transcriptional Control of Chronic Fatigue Syndrome Revealed in Molecular Medicine 2Health News:Genes Seem to Affect Tissues Differently 2Health News:Circumcision Rates Too Low 2Health News:What is the mechanism of the chronic radiation enteritis? 2Health News:Take the Holiday to the Hospital 2
(Date:12/4/2009)...., Dec. 4 Drs. Neal Shore and E. D...fic antigen (PSA) recurrence from the additional a...urrence rate in a Phase III pivotal study of FIRMA...thly leuprolide in prostate cancer patients during...ients who received FIRMAGON 240/80 mg/month had a ...
(Date:12/3/2009)...s., Dec. 3 Allen Medical...(NYSE: HRC ), today announced the launch of its ...facturer) business website www.AllenAmatech.com ...(TM) brand identity and includes an online version...tions and design specifications for the products. ...
(Date:12/3/2009)...Dec. 3 BioMed Realty Tru...s entered into a new lease with Regeneron Pharmace...31,000 square feet of additional, newly-constructe...astview campus in Tarrytown, New York. The new lea...nal space was completed approximately two months a...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3Facial Plastic Surgeon Dr Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51924 1Facial Plastic Surgeon Dr Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51924 2Facial Plastic Surgeon Dr Frank Fechner Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 51924 3STD Test Express Offers Free Doctor Consultations With Every STD Test 51921 1STD Test Express Offers Free Doctor Consultations With Every STD Test 51921 2Reliv Internationals GlucAffect 28TM 29 Proven Effective in Clinical Study 4735 1Reliv Internationals GlucAffect 28TM 29 Proven Effective in Clinical Study 4735 2
...y--(BUSINESS WIRE)--Mar 23, 2007 - ZIOPHARM,Oncolo...tation of,data on ZIO-201 at the XXXI World Congre...) meeting being held in Punta del Este,Uruguay. Z...tive,metabolite of ifosfamide (IFOS), a drug that ...er, IFOS can be problematic in treating,lymphoma a...
...gests the Drug Improves Memory, SARASOTA, Fla., Ma... Institute announced today that it has received po...tudy that is testing a,promising new drug applicat...clinical study, which was first announced in,Septe...by a,Florida-based research institute as a result ...
Other Medicine Technology:ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH 2ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH 3Sarasota's Roskamp Institute Announces Positive Safety Data in,Human Clinical Study for Alzheimer's Disease 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: